[White Paper] GCC Recommendations on Bioanalytical Method Stability Implications of Co-administered and Co-formulated Drugs
An Open Letter written by the GCC describing the GCC survey results on stability data from co-administered and co-formulated drugs was sent to multiple regulatory authorities on 14 December 2011. This letter and further discussions at different GCC meetings lead to subsequent recommendations on this topic of widespread interest within the bioanalytical community over the past two years.
